Sulphamidase Activity in Leucocytes, Cultured Skin Fibroblasts and Amniotic Cells: Diagnosis of the Sanfilippo a Syndrome with the Use of a Radiolabelled Disaccharide Substrate

1981 ◽  
Vol 61 (6) ◽  
pp. 729-735 ◽  
Author(s):  
J. J. Hopwood ◽  
Helen Elliott

1. Sulphamidase activity was assayed by incubation of the radiolabelled disaccharide O-(α-2-sulphamino-2-deoxy-d-glucopyranosyl)-(1 → 3)-l-[6-3H]idonic acid with homogenates of leucocytes and cultured skin fibroblasts and concentrates of urine derived from normal individuals, patients affected with sulphamidase deficiency disorder [mucopolysaccharidosis type IIIA (MPS IIIA): the Sanfilippo A syndrome], parents of such patients and patients affected with other mucopolysaccharidoses and lysosomal enzyme deficiencies. 2. the assay clearly distinguished affected homozygotes from normal controls, heterozygotes and other mucopolysaccharidoses types. 3. Sulphamidase displayed remarkable thermal stability; reaction rates were constant for at least 24 h at 60°C for leucocyte and 20 h at 37°C for cultured fibroblast preparations. Apparent Km values for fibroblast sulphamidase were 71 μmol/l at 37°C and 100 μmol/l at 50°C; the corresponding Vmax. values were 21 and 71 pmol min−1 mg−1 of protein respectively. an incubation temperature of 60h°C was used for the routine assay of sulphamidase activity in leucocytes, urine and amniotic supernatant preparations. the specific activities of fibroblast and amniotic cell sulphamidase, assessed at incubation temperatures of 37°C, were more than 10-fold the leucocyte enzyme activity at 60°C. 4. We recommend the use of radiolabelled disaccharide substrate for the assay of sulphamidase in leucocytes, skin fibroblasts and urine, for the routine enzymic detection of the sulphamidase deficiency disorder of the Sanfilippo A syndrome.

1979 ◽  
Vol 57 (3) ◽  
pp. 265-272 ◽  
Author(s):  
J. J. Hopwood ◽  
Vivienne Muller

1. Homogenates of cultured skin fibroblasts derived from patients with α-l-iduronidase-deficiency disorders (Hurler and Scheie syndromes) were capable of hydrolysing iduronosyl anhydro-[l-3H]mannitol 6-sulphate although at considerably reduced rates compared with normal controls. 2. The Vmax. values of α-l-iduronidase from patients with Hurler or Scheie syndromes and from normal controls were 11, 12 and 833 pmol min−1 mg−1 of protein respectively; the corresponding apparent Km values were 656, 50 and 53 μmol/l respectively. The α-l-iduronidases from normal and Scheie fibroblast homogenates were shown to exhibit pH optima at 3·6 and 4·1 and were competitively inhibited by both chloride and sulphate ions: Hurler α-l-iduronidase activity exhibited one pH optimum at 3·8 and was also inhibited by chloride and to a lesser extent by sulphate ions. 3. The thermal stability of Hurler, Scheie and normal α-l-iduronidase activities at 55°C gave half-lives of approximately 1·0, 2·5 and 1·0 h respectively. 4. These biochemical findings clearly demonstrate enzyme differences for these two clinically distinct phenotypes and provide biochemical evidence that the Hurler and Scheie syndromes result from different allelic mutations.


1986 ◽  
Vol 238 (2) ◽  
pp. 589-595 ◽  
Author(s):  
A L Miller ◽  
R Stein ◽  
M Sundsmo ◽  
R Y Yeh

Chediak-Higashi-syndrome cultured skin fibroblasts were used to study the possible involvement of lysosomal enzymes and lysosomal dysfunction in this disorder. Our evidence indicated that Chediak-Higashi fibroblasts displayed a significant decrease in the specific activity of the acidic alpha-D-mannosidase (pH 4.2) compared with normal controls. Additional studies revealed a small, but significant, decrease in the rate of degradation of 125I-labelled beta-D-glucosidase that had been endocytosed into Chediak-Higashi cells.


1979 ◽  
Vol 56 (6) ◽  
pp. 591-599 ◽  
Author(s):  
J. J. Hopwood ◽  
Vivienne Muller ◽  
A. C. Pollard

1. α-l-Iduronidase activity was assayed by incubation of iduronosyl anhydro[1-3H]mannitol 6-sulphate with homogenates of cultured skin fibroblasts, amniotic cells and leucocytes derived from normal individuals, patients affected with α-l-iduronidase deficiency disorder (mucopolysaccharidosis type I: Hurler, Scheie and Hurler-Scheie compound) and parents of such patients. 2. The assay for α-l-iduronidase, described for use with these cell types, clearly distinguished affected homozygotes from heterozygotes and normal controls. 3. The mean specific activity of α-l-iduronidase in homogenates prepared from cultured skin fibroblasts and leucocytes from more than seven obligate heterozygotes for mucopolysaccharidosis type I was found to be about one-half of the mean of more than 40 normal controls. A number of heterozygotes had α-l-iduronidase activity that identified them as carriers; others had values clearly within the normal range. Thus heterozygote detection of mucopolysaccharidosis type I is not certain. 4. With iduronosyl anhydro[1-3H]mannitol 6-sulphate used as substrate, cell types from five pregnancies at risk for α-l-iduronidase deficiency were examined; each foetus was predicted to be unaffected. For one foetus it was not possible from measurements of total enzyme activity alone to distinguish between the heterozygous carrier state and affected homozygote. The difficulty was resolved by comparing Michaelis-Menten kinetics of this enzyme in fibroblasts derived from the propositus, mother and normal controls with the kinetics of the enzyme in amniotic cells isolated from the foetus at risk and from normal controls.


1981 ◽  
Vol 26 (1) ◽  
pp. 28-40 ◽  
Author(s):  
Jun Oizumi ◽  
Tullio A. Giudici ◽  
Won G. Ng ◽  
Kenneth N.F. Shaw ◽  
George N. Donnell

Sign in / Sign up

Export Citation Format

Share Document